Use of nicotinamide n-methyltransferase as a marker for...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01) C12Q 1/48 (2006.01)

Patent

CA 2510377

The present invention relates to the diagnosis of colorectal cancer. It discloses the use of the protein nicotinamide N-methyltransferase (NNMT) in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a liquid sample, derived from an individual by measuring NNMT in said sample. Measurement of NNMT can, e.g., be used in the early detection or diagnosis of colorectal cancer.

La présente invention concerne le diagnostic du cancer colorectal. L'invention concerne également l'utilisation de la protéine nicotinamide N-méthyltransférase (NNMT) dans le diagnostic du cancer colorectal. L'invention concerne en outre une méthode de diagnostic du cancer colorectal à partir d'un échantillon de liquide prélevé chez un individu, par mesure de la NNMT dans ledit échantillon. La mesure de la NNMT peut, par exemple, être utilisée dans la détection ou le diagnostic précoce du cancer colorectal.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of nicotinamide n-methyltransferase as a marker for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of nicotinamide n-methyltransferase as a marker for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nicotinamide n-methyltransferase as a marker for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1857065

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.